News Ticker

[ October 6, 2026 ] City of Hope Names New Presidents of Cancer Centers in Arizona and Atlanta Los Angeles Biotech News
[ October 6, 2026 ] MidFirst Bank Donates $35,000 to The Heart Foundation to Support Heart Disease Research and Awareness Los Angeles Biotech News
[ October 6, 2026 ] New World Medical Receives MDR Certification for Ahmed® Glaucoma Valve, Ahmed ClearPath®, and KDB GLIDE® Los Angeles Biotech News
[ October 6, 2026 ] Infleqtion, Honeywell Aerospace and UC Santa Barbara Collaborate to Accelerate Miniaturization and Manufacturability of Quantum Hardware Los Angeles Biotech News
[ October 6, 2026 ] Prostate Cancer Foundation Honors Mary-Ellen Taplin, MD, with the 2026 PCF Women in Science Lifetime Achievement Award Los Angeles Biotech News

Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer

March 7, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

IRVINE, Calif., March 7, 2022 /PRNewswire/ — Helio Health ("Helio"), an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw, today announced that Hepatology Communications published positive results from the ENCORE study…

Copyright © 2026 Biotech Networks, LLC